Amarin (ADR)
Commercializes icosapent ethyl for cardiovascular care through Vascepa and Vazkepa.
$13.97
After-hours close0.00 (0.00%)
At close$13.97(−0.71%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 22.53%Insiders —
Shares outstanding 20.68M · Float —
Insiders — filings are in the shares behind the receipt.
This listing is a depositary receipt and the Form 4 positions here are filed in the shares behind it, a different unit from the share count and in a ratio the filings never state, so no insider percentage is shown.
Institutions13F, as of Jun 30, 2026
86 holders · 4.66M shares · 23 new positions · 39 increased · 12 reduced · 8 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Sarissa Capital Management LP | 1.67M | 8.09% | 0 | Aug 14, 2026 |
| Acadian Asset Management LLC | 721.0K | 3.49% | +84.2K | Aug 13, 2026 |
| Kynam Capital Management, LP | 533.0K | 2.58% | +60.6K | Aug 14, 2026 |
| Morgan Stanley | 223.6K | 1.08% | −69.6K | Aug 13, 2026 |
| Waterfront Wealth Inc. | 213.9K | 1.03% | +10.6K | Jul 30, 2026 |
| Brooklands Fund Management Ltd | 177.3K | 0.86% | +177.3K | Aug 11, 2026 |
| Eversept Partners, LP | 145.3K | 0.70% | −2.4K | Aug 14, 2026 |
| Millennium Management LLC | 115.8K | 0.56% | −184.7K | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Sarissa Capital Management LPincl. Alexander J Denner | 6.09% | 13D | Aug 27, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | Filed |
|---|---|---|---|
| Aaron Berg | officer: President and CEO | 85.6K | Jun 30, 2026 |
| Steven B. Ketchum | officer: EVP, Chief Scientific Officer | 42.7K | Jul 15, 2026 |
| David Paul Keenan | officer: EVP, Chief Operating Officer | 13.5K | Jul 15, 2026 |
| Peter L. Fishman | officer: SVP, CFO | 7.6K | Aug 3, 2026 |
| Jonathan Provoost | officer: EVP, Chief Legal Officer | 4.6K | Jul 15, 2026 |
| Louis III Sterling | director | 4.0K | Apr 21, 2026 |
| Patrice Eadon Bonfiglio | director | 836 | Apr 22, 2026 |
| Paul Cohen | director | 836 | Apr 21, 2026 |
| Keith Horn | director | 836 | Apr 21, 2026 |
| Kostas D. Odysseas | director | 836 | Apr 21, 2026 |
26 positions are filed in the unlisted share unit (4.86M shares), which no share count here divides
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.